Vanda Pharmaceuticals Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC VNDA

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

500,515

Value ($000)

4,415

Weight

0.0%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	4,415	0.0%	500,515	12/31/2025
2025 Q3	11/10/2025	2,440	0.0%	488,936	9/30/2025
2025 Q2	8/12/2025	2,125	0.0%	450,207	6/30/2025
2025 Q1	9/15/2025	2,184	0.0%	475,865	3/31/2025
2024 Q4	2/6/2025	2,675	0.0%	558,446	12/31/2024
2024 Q3	11/12/2024	2,796	0.0%	596,210	9/30/2024
2024 Q2	8/12/2024	3,349	0.0%	592,737	6/30/2024
2024 Q1	5/9/2024	2,746	0.0%	668,180	3/31/2024
2023 Q4	2/6/2024	2,722	0.0%	645,129	12/31/2023
2023 Q3	11/8/2023	2,792	0.0%	646,248	9/30/2023
2023 Q2	8/10/2023	4,205	0.0%	638,072	6/30/2023
2023 Q1	5/12/2023	4,294	0.0%	632,357	3/31/2023
2022 Q4	2/13/2023	4,915	0.0%	665,035	12/31/2022
2022 Q3	11/14/2022	6,372	0.0%	644,856	9/30/2022
2022 Q2	8/15/2022	6,916	0.0%	634,478	6/30/2022
2022 Q1	5/13/2022	7,684	0.0%	679,382	3/31/2022
2021 Q4	2/11/2022	11,098	0.0%	707,292	12/31/2021
2021 Q3	11/16/2021	10,968	0.0%	639,882	9/30/2021
2021 Q2	8/16/2021	11,937	0.0%	554,907	6/30/2021
2021 Q1	5/17/2021	6,172	0.0%	410,857	3/31/2021
2020 Q4	2/16/2021	4,682	0.0%	356,282	12/31/2020
2020 Q3	11/13/2020	3,425	0.0%	354,551	9/30/2020
2020 Q2	8/20/2020	4,067	0.0%	355,474	6/30/2020
2020 Q1	5/15/2020	3,404	0.0%	328,501	3/31/2020
2019 Q4	2/7/2020	6,966	0.0%	424,475	12/31/2019
2014 Q2	7/30/2014	766	0.0%	47,300	6/30/2014
2014 Q1	4/29/2014	769	0.0%	47,300	3/31/2014
2013 Q4	2/14/2014	587	0.0%	47,300	12/31/2013